Eaton Vance Worldwide Health Sciences is a solid source of global healthcare exposure, rather than a superior one.
Eaton Vance Worldwide Health Sciences Fund Class R ERHSX
- NAV / 1-Day Return 14.56 / −1.29 %
- Total Assets 790.7M
-
Adj. Expense Ratio
1.430%
- Expense Ratio 1.420%
- Distribution Fee Level Average
- Share Class Type Retirement, Medium
- Category Health
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.21%
- Turnover 30%
USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:10 AM GMT+0
Morningstar’s Analysis ERHSX
Will ERHSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 58.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 12.51 | 95M | Healthcare |
AbbVie Inc | 6.47 | 49M | Healthcare |
Johnson & Johnson | 6.47 | 49M | Healthcare |
AstraZeneca PLC | 6.26 | 47M | Healthcare |
UnitedHealth Group Inc | 5.50 | 42M | Healthcare |
Roche Holding AG | 5.46 | 41M | — |
Merck & Co Inc | 5.09 | 38M | Healthcare |
Bristol-Myers Squibb Co | 4.27 | 32M | Healthcare |
Vertex Pharmaceuticals Inc | 3.39 | 26M | Healthcare |
Gilead Sciences Inc | 3.35 | 25M | Healthcare |